These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7644626)

  • 21. Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats.
    Jara A; von Höveling A; Jara X; Burgos ME; Valdivieso A; Mezzano S; Felsenfeld AJ
    Nephrol Dial Transplant; 2006 Apr; 21(4):917-23. PubMed ID: 16431896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin-receptor blockade mitigates the adverse effect of preretrieval warm ischemia on posttransplantation renal function in rats.
    Inman SR; Plott WK; Pomilee RA; Antonelli JA; Lewis RM
    Transplantation; 2003 May; 75(10):1655-9. PubMed ID: 12777851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.
    Sogni P; Moreau R; Gomola A; Gadano A; Cailmail S; Calmus Y; Clozel M; Lebrec D
    Hepatology; 1998 Sep; 28(3):655-9. PubMed ID: 9731554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.
    Ding SS; Qiu C; Hess P; Xi JF; Clozel JP; Clozel M
    Cardiovasc Res; 2002 Mar; 53(4):963-70. PubMed ID: 11922906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effect of ETA receptor blockade in a rat model of radiocontrast-induced nephropathy.
    Pollock DM; Polakowski JS; Wegner CD; Opgenorth TJ
    Ren Fail; 1997 Nov; 19(6):753-61. PubMed ID: 9415932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET(A) receptor antagonist.
    Yuyama H; Sanagi M; Koakutsu A; Mori M; Fujimori A; Harada H; Sudoh K; Miyata K
    Eur J Pharmacol; 2003 Sep; 478(1):61-71. PubMed ID: 14555186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of cyclosporine-induced nephrotoxicity.
    Ishikawa A; Suzuki K; Fujita K
    Transplant Proc; 1999; 31(1-2):1127-8. PubMed ID: 10083503
    [No Abstract]   [Full Text] [Related]  

  • 28. Contrast media-induced nephrotoxicity. Survey and present state.
    Golman K; Almén T
    Invest Radiol; 1985; 20(1 Suppl):S92-7. PubMed ID: 3972531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotoxicity from contrast media: attenuation with theophylline.
    Morcos SK; Brown PW
    Radiology; 1995 Nov; 197(2):546-7; dicussion 248. PubMed ID: 7480713
    [No Abstract]   [Full Text] [Related]  

  • 30. The Role of Endothelin System in Renal Structure and Function during the Postnatal Development of the Rat Kidney.
    Albertoni Borghese MF; Ortiz MC; Balonga S; Moreira Szokalo R; Majowicz MP
    PLoS One; 2016; 11(2):e0148866. PubMed ID: 26872270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis.
    Hogaboam CM; Muller MJ; Collins SM; Hunt RH
    Eur J Pharmacol; 1996 Aug; 309(3):261-9. PubMed ID: 8874149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bosentan reduces blood pressure and the target-organ damage induced by a high-fructose diet in rats.
    Cosenzi A; Bernobich E; Plazzotta N; Seculin P; Bellini G
    J Hypertens; 1999 Dec; 17(12 Pt 2):1843-8. PubMed ID: 10703878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nonpeptide endothelin receptor antagonists in rats with reduced renal mass.
    Clozel M; Qiu C; Osterwalder R; Roeckel A; Bruneval P; Heudes D; Clozel JP
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):611-8. PubMed ID: 10218732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function following nephroangiography with diatrizoate. Effects of saline, mannitol, and diatrizoate on renal blood flow, glomerular permeability and filtration rate and diuresis in dogs.
    Törnquist C; Almén T; Golman K; Holtås S
    Acta Radiol Diagn (Stockh); 1984; 25(4):343-50. PubMed ID: 6435396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of radiocontrast-induced nephrotoxicity by the endothelin receptor antagonist, SB 209670.
    Brooks DP; DePalma PD
    Nephron; 1996; 72(4):629-36. PubMed ID: 8730433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet.
    Wesson DE; Simoni J
    Kidney Int; 2010 Dec; 78(11):1128-35. PubMed ID: 20861823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodynamic effects of water-soluble contrast media on the isolated perfused rat kidney.
    el Sayed AA; Haylor JL; el Nahas AM; Salzano S; Morcos SK
    Br J Radiol; 1991 May; 64(761):435-9. PubMed ID: 2036568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure.
    Anand R; Harry D; Holt S; Milner P; Dashwood M; Goodier D; Jarmulowicz M; Moore K
    Gut; 2002 Jan; 50(1):111-7. PubMed ID: 11772977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast media induced changes in tubular electrophysiology and glomerular filtration rate in the mouse kidney.
    Morgunov NS; Foster SG; Hirsch DJ
    Can J Physiol Pharmacol; 1997 Aug; 75(8):988-95. PubMed ID: 9360013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy.
    Heyman SN; Clark BA; Cantley L; Spokes K; Rosen S; Brezis M; Epstein FH
    Invest Radiol; 1993 Apr; 28(4):313-8. PubMed ID: 8478171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.